The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin-Reference-Cited by-同舟云学术

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

Published:2019-03-28 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Cuyàs Elisabet,Buxó Maria,Ferri Iglesias Maria José,Verdura Sara,Pernas Sonia,Dorca Joan,Álvarez Isabel,Martínez Susana,Pérez-Garcia Jose Manuel,Batista-López Norberto,Rodríguez-Sánchez César A.,Amillano Kepa,Domínguez Severina,Luque Maria,Morilla Idoia,Stradella Agostina,Viñas Gemma,Cortés Javier,Joven Jorge,Brunet Joan,López-Bonet Eugeni,Garcia Margarita,Saidani Samiha,Queralt Moles Xavier,Martin-Castillo Begoña,Menendez Javier A.

Funder

Ministerio de Ciencia e Innovación

Ministerio de Sanidad, Servicios Sociales e Igualdad

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference34 articles.

1. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes;Zhou;Nat Genet.,2011

2. The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program;Florez;Diabetes Care.,2012

3. A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts;van Leeuwen;Diabetologia.,2012

4. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin;Zhou;Nat Genet.,2016

5. A gene variant near ATM affects the response to metformin and metformin plasma levels: a post hoc analysis of an RCT;Out;Pharmacogenomics.,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma;Frontiers in Oncology;2024-08-29

2. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06

3. Ianus Bifrons: The Two Faces of Metformin;Cancers;2024-03-26

4. Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications;Biomedicine & Pharmacotherapy;2023-06

5. Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial;Breast Cancer Research and Treatment;2022-12-16